Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cal Gary who wrote (8547)	1/28/2002 9:22:35 PM
From: DaveAu	Read Replies (4) of 14101

Cal/Joe, <<'ll have to go with Joe on this, they 'formally' announced July 18 to acquire OXO 'as soon as the blind was lifted'. The blind was originally expected June 2001, but confirmed to be early-mid July 2001.>> I appreciate all the info you two have provided on this board. I think you're two of the most valuable posters. I also think you've both picked up some serious mis-information about the WF10 phase 3. The study has not been un-blinded. Neither DMX or Oxo has ever indicated that it was unblinded yet. In the CC today, Rebecca stated something like "we need to verify all the data before the database can be locked". That's another way of saying that the blind has not yet been broken. And that is actually very good news. It puts to rest my AXO analogy - the reason for the delay is not that they're massaging the data trying to find sub-groups where the drug actually worked. It does raise a question however about the competency of the Oxo Chemie staff that were responsible for overseeing the trial. Will we be able to use all the patients that were enrolled or has some of the information not been properly maintained ? Back to waiting.. Dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next